GlassScriptPhysician profile
Michael P Starkweather
NPI 1417984238
$3,919.07
in general payments reported to CMS, 2019-2025
10 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.37 · 2020: $18.60 · 2021: $117 · 2022: $263 · 2023: $2,355 · 2024: $118 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,899 · Food and Beverage: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,899.46 |
| Food and Beverage | $1,571.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,958.67 | 2022-2025 | |
| Evolution Surgical, INC | $630.39 | 2023-2025 | |
| Stryker Corporation | $567.79 | 2019-2024 | Salvation, Augment Injectable, Ortholoc 2 Lapifuse |
| Arthrex, INC. | $366.06 | 2025 | |
| Smith+Nephew, INC. | $188.94 | 2022-2023 | Cadence, Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $53.32 | 2023 | Motoband, Na, Minibunion |
| Bioventus LLC | $50.60 | 2023 | Exogen Ultrasound Bone Healing System |
| Crossroads Extremity Systems, LLC | $44.41 | 2021 | |
| Sanara Medtech INC. | $38.37 | 2023 | Celleraterx |
| Kerecis Limited | $20.52 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Starkweather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.